Testing how a new weight-loss medication interacts with common drugs

This is a Phase 1 trial testing a new medication called HDM1002, which is being developed to help with weight management. Researchers want to understand how this medication behaves in your body when you also take other common drugs — like medications for diabetes, blood pressure, blood clotting, anxiety, and sleep. By studying these interactions carefully, doctors can make sure the treatment is safe and effective when people need to take multiple medications at the same time.

Before this medication can be widely prescribed, scientists need to understand whether it's safe to take it alongside other drugs that patients commonly use. This information helps doctors avoid dangerous drug interactions and ensure the treatment works properly for real-world patients who take multiple medications.